Abstract
The term 'spondyloarthritis', which is preferred to 'spondyloarthropathy', refers to a group of similar diseases with distinct clinical features and a common genetic predisposition, rather than one disease with different clinical presentations. Mainly for clinical purposes, five disease subtypes are recognized: ankylosing spondylitis (AS), psoriatic spondyloarthritis, reactive spondyloarthritis, spondyloarthritis associated with inflammatory bowel disease, and undifferentiated spondyloarthritis. Irrespective of the disease subtype, the main clinical manifestations of spondyloarthritides are inflammatory back pain, peripheral arthritis, enthesitis and anterior uveitis, while other organ manifestations are rare. The need for a standardized, evidence-based approach to disease classification led to the development of the European Spondyloarthropathy Study Group preliminary criteria for spondyloarthritis in 1991, which confirmed the unifying concept of this group of diseases. In the past 10 years, the work of the European Spondyloarthropathy Study Group has been taken over by the Assessments in AS working group. There is still a considerable delay in diagnosis of AS and, because of the well-documented efficacy of anti-tumor-necrosis-factor therapy for all spondyloarthritis subtypes, diagnostic criteria (especially for early forms of spondyloarthritis) are needed. Diagnosis can be achieved by determination of the predominant clinical manifestation, and by the inclusion of sensitive diagnostic tools for early disease (such as HLA-B27 genotype and MRI) in the criteria set. In addition, because of the high incidence of back pain in affected individuals, the development of practical screening parameters that facilitate referral to the rheumatologist is important.
Key Points
-
The most frequent, predominant symptoms of spondyloarthritides are inflammatory back pain and asymmetric peripheral arthritis
-
Currently, the mean delay between onset of first symptoms and making a diagnosis of ankylosing spondylitis is over 5 years
-
The availability of effective therapies makes an early diagnosis mandatory
-
The clinical symptoms of inflammatory back pain, structural changes in the sacroiliac joints as seen on X-ray, active inflammation as seen by MRI, and positivity for HLA-B27 are the most important parameters for an early diagnosis of spondyloarthritis, especially in combination
-
A combination of clinical and laboratory parameters is necessary for the early diagnosis of both predominantly peripheral and predominantly axial spondyloarthritis
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Braun J et al. (2002) Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience. Ann Rheum Dis 61 (Suppl 3): iii51–iii60
Francois RJ et al. (1995) Commented glossary for rheumatic spinal diseases, based on pathology. Ann Rheum Dis 54: 615–625
Brandt J et al. (1999) Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy. Rheumatology 38: 831–836
Braun J et al. (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52: 2447–2451
Lautermann D and Braun J (2002) Ankylosing spondylitis—cardiac manifestations. Clin Exp Rheumatol 20 (Suppl 28): S11–S15
Brown MA et al. (2002) Genetics of ankylosing spondylitis. Clin Exp Rheumatol 20 (Suppl 28): S43–S49
Said-Nahal R et al. (2001) Groupe Francais d'Etude Genetique des Spondylarthropathies. Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy. Arthritis Rheum 45: 478–484
Zochling J et al. (2005) The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (Oxford) 44: 1483–1491
Kahn MF and Khan MA (1994) The SAPHO syndrome. Baillieres Clin Rheumatol 8: 333–362
Braun J et al. (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41: 58–67
Braun J et al. (2005) Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: comment on the article by Braun et al. Arthritis Rheum 52: 4049–4050
Saraux A et al. (2005) Prevalence of spondylarthropathies in France: 2001. Ann Rheum Dis 64: 1431–1435
Feldtkeller E et al. (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23: 61–66
Braun J et al. (2005) Therapy of ankylosing spondylitis—a review. Part I: conventional medical treatment and surgical therapy. Scand J Rheumatol 34: 97–108
Braun J et al. (2005) Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides. Scand J Rheumatol 34: 178–190
Wanders A et al. (2005) Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation? Ann Rheum Dis 64: 988–994
Dougados M et al. (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34: 1218–1227
McGonagle D et al. (1998) Classification of inflammatory arthritis by enthesitis. Lancet 352: 1137–1140
van der Heijde D et al. (1999) Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol 26: 951–954
van der Heijde D et al. (2005) Assessments in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis. Arthritis Rheum 52: 386–394
Zochling J et al. (2005) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65: 442–452
Braun J et al. (2005) First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65: 316–320
Rudwaleit M et al. (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63: 535–543
Baraliakos X et al. (2004) Inflammation in ankylosing spondylitis: a systematic description of the extension and frequency of acute spinal changes using magnetic resonance imaging (MRI). Ann Rheum Dis 64: 730–734
Bollow M et al. (2002) Use of contrast enhanced magnetic resonance imaging to detect spinal inflammation in patients with spondyloarthritides. Clin Exp Rheumatol 20 (Suppl 28): S167–S174
Rudwaleit M et al. (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52: 1000–1008
Sieper J and Rudwaleit M (2005) Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann Rheum Dis 64: 659–663
Kellgren JH et al. (eds; 1963) The epidemiology of chronic rheumatism, vol. 1, 326. Oxford: Blackwell
Bennett PH and Wood PHN (eds; 1968) Population studies of the rheumatic diseases, 456–457 Amsterdam: Elsevier (Excerpta Medica)
van der Linden S et al. (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27: 361–368
Davis JC Jr et al. (2003) The Enbrel Ankylosing Spondylitis Study Group. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48: 3230–2326
van der Heijde D et al. (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis—results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 52: 582–591
Boyer GS et al. (1993) Evaluation of the European Spondylarthropathy Study Group preliminary classification criteria in Alaskan Eskimo populations. Arthritis Rheum 36: 534–538
Amor B et al. (1990) Criteria of the classification of spondylarthropathies [French]. Rev Rhum Mal Osteoartic 57: 85–89
Mau W et al. (1998) Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol 15: 1109–1114
Collantes-Estevez E et al. (1995) Assessment of 2 systems of spondyloarthropathy diagnostic and classification criteria (Amor and ESSG) by a Spanish multicenter study. European Spondyloarthropathy Study Group. J Rheumatol 22: 246–251
Amor B et al. (1995) Are classification criteria for spondylarthropathy useful as diagnostic criteria? Rev Rhum Engl Ed 62: 10–15
Heuft-Dorenbosch L et al. (2005) Combining information obtained from magnetic resonance imaging and conventional radiographs to detect sacroiliitis in patients with recent onset inflammatory back pain. Ann Rheum Dis 65: 804–808
Baraliakos X et al. (2005) Radiographic progression in patients with ankylosing spondylitis after two years of treatment with the tumor necrosis factor-α antibody infliximab. Ann Rheum Dis 64: 1462–1466
Calin A et al. (1977) Clinical history as a screening test for ankylosing spondylitis. JAMA 237: 2613–2614
Rudwaleit M et al. (2006) Inflammatory back pain in ankylosing spondylitis—a reassessment of the clinical history for classification and diagnosis. Arthritis Rheum 54: 569–578
Spoorenberg A et al. (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26: 980–984
Braun J et al. (1994) Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 37: 1039–1045
Oostveen J et al. (1999) Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. J Rheumatol 26: 1953–1958
Braun J and van der Heijde D (2002) Imaging and scoring in ankylosing spondylitis. Best Pract Res Clin Rheumatol 16: 573–604
Braun J et al. (2003) MRI examinations of the spine in patients with ankylosing spondylitis (AS) before and after infliximab therapy after evaluation of a new scoring system. Arthritis Rheum 48: 1126–1136
Rudwaleit M et al. (2005) Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. Ann Rheum Dis 64: 1305–1310
D'Agostino MA et al. (2003) Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 48: 523–533
Kane D et al. (2001) The role of ultrasonography in the diagnosis and management of idiopathic plantar fasciitis. Rheumatology (Oxford) 40: 1002–1008
Balint PV et al. (2002) Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 61: 905–910
Underwood MR and Dawes P (1995) Inflammatory back pain in primary care. Br J Rheumatol 34: 1074–1077
Sieper J et al. (2002) Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 46: 319–327
Helliwell PS and Taylor WJ (2005) Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 64 (Suppl 2): ii3–ii8
McGonagle D et al. (2002) The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy. Arthritis Rheum 46: 489–493
Mielants H et al. (1995) The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 22: 2266–2272
Grimes DA and Schulz KF (2005) Refining clinical diagnosis with likelihood ratios. Lancet 365: 1500–1505
Acknowledgements
Both authors have made equal contributions to this article.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Braun, J., Sieper, J. Early diagnosis of spondyloarthritis. Nat Rev Rheumatol 2, 536–545 (2006). https://doi.org/10.1038/ncprheum0296
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0296
This article is cited by
-
The effect of uveitis and undiagnosed spondyloarthritis: a systematic review and meta-analysis
Scientific Reports (2023)
-
Real-World Patient Experience on the Path to Diagnosis of Ankylosing Spondylitis
Rheumatology and Therapy (2019)
-
Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey
Rheumatology and Therapy (2019)
-
The usefulness of bone SPECT/CT imaging with volume of interest analysis in early axial spondyloarthritis
BMC Musculoskeletal Disorders (2015)
-
Spondyloarthritiden
Der Internist (2011)